A New Short-Term Portfolio: Microbot Medical Inc. (MBOT)

Gadot Harel, Chairman, President and CEO, subtracted 40,000 shares of Microbot Medical Inc. (MBOT) from its portfolio at the rate of $10.00 per share valuing $400,000 on Dec 23. The insider left behind 136,847 shares of the company to its portfolio. Currently, the 1st Resistance Point for this stock is $14.74, with a 2nd Resistance Point sitting at $16.99. Meanwhile, this company’s stock has a 1st Support Level at $11.24 and a 2nd Support Level at $9.99. Before making a move on any particular stock, readers often pay close attention to support and resistance markers. The last reported price for shares of Microbot Medical Inc. (MBOT) was $12.48. Microbot Medical Inc. (MBOT) stock has gained $0.63, or 5.32%, in the past five days. In the last full month, these shares have gained $6.23, or 99.68%. In the past three months, this stock’s price has risen by $7.07, or 130.68%. This year-to-date, Microbot Medical Inc. (MBOT) shares have gained $2.31, or 22.71%.

Analyzing price projection indicators is a helpful way to determine whether a potential stock buy is a wise choice for profits in the short term, medium term, and long term. For Microbot Medical Inc. (MBOT) stock, 100% of short-term indicators suggest that these shares are a “ Buy .” Meanwhile, 100% of medium-term indicators point to this stock being a “ Buy .” Looking further ahead, 75% of long-term indicators suggest that this stock is a “ Buy .”

With 6,285 K shares outstanding, this company currently has a market capitalization of $82,769K. Microbot Medical Inc. (MBOT) generates annual net income of -$7,240 K. This stock has generated a 1-Year Total Return of 420.00%, a 3-Year Total Return of -85.54%, and a 5-year Total Return of -99.23%. This stock’s 5-Year Dividend Growth is 0.00%. Its Annual Dividend Yield is 0.00%, and its Annual Dividend Rate is 0.00.

In the most recently-reported fiscal quarter, which ended in 09/19, Microbot Medical Inc. (MBOT) reported earnings of -$0.44 per share. Wall Street analysts, on average, were expecting the company to report earnings of -$0.44 per share, representing equal. In the previous quarter ending in 06/19, the reported earnings of -$0.36 represented a 0.09 difference from the consensus estimate calling for -$0.45 per share, which was a 20.00% surprise.

For the current fiscal quarter, which is set to end in 12/2019, the average earnings estimate is -$0.39 per share. This estimate came from a total of 1 Wall Street Analysts. Of those market experts, the high estimate was -$0.39 and the low estimate was -$0.39. In the year-ago quarter, Microbot Medical Inc. (MBOT) generated per-share earnings of -$0.72. If the analysts are correct about the current quarter’s earnings, the growth will be +45.83%.

Turning our focus now to insider trading activity, there have been 0 purchases (0 shares in total) and 1 sale (40,000 shares in total) in the last 3 months. In the last 6 months, there have been 0 insider buys amounting to 0 shares and 1 insider sales amounting to 40,000 shares. In the past full year, 5 insider purchases were made (involving 306,316 shares) and 6 insider sell-offs equivalent to 714,543 shares.

Moving onto liquidity, Microbot Medical Inc. (MBOT) has a Current Ratio of 1.14, a Quick Ratio of 1.14 and a Cash Ratio of 1.11. Looking even further ahead into the future, its Long-Term Debt to Equity is -3,622.00.